Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
19-22 October, 2025
Not Confirmed
Not Confirmed
20-22 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
19-22 October, 2025
Industry Trade Show
Not Confirmed
20-22 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-are-building-capabilities-to-stay-ahead-of-the-curve-and-align-with-future-needs-of-global-healthcare
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
14 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/metavia-to-present-at-the-hc-wainwright-liver-disease-virtual-conference-302582872.html
26 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/metavia-to-present-at-upcoming-investor-and-industry-conferences-302536713.html
08 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/metavia-reports-second-quarter-2025-financial-results-and-provides-corporate-update-302523790.html
07 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/metavia-extends-48-mg-mad-portion-of-its-phase-1-clinical-trial-of-da-1726-for-the-treatment-of-obesity-to-8-weeks-and-announces-fifth-weekly-dose-in-first-patient-302522928.html
04 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/metavia-announces-ai-driven-collaboration-with-syntekabio-to-explore-additional-indications-for-da-1241-302520330.html
09 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/metavia-doses-first-patient-in-the-48-mg-mad-cohort-of-its-phase-1-clinical-trial-evaluating-da-1726-for-the-treatment-of-obesity-to-further-explore-maximum-tolerated-dose-302501196.html
ABOUT THIS PAGE